🔎 Trials Near Me

Nyumbani › Kushindwa kwa Moyo

Majaribio ya kliniki ya Kushindwa kwa Moyo yanayovutia washiriki nchini Marekani

Masomo 220 ya Kushindwa kwa Moyo yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

ELEVATE-HFpEF Clinical Study

Inaajiri
Umri 40 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06678841

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03523416

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

InaajiriHatua 3
Umri 18 hadi 130 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06307652

Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07467668

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

InaajiriHatua 1
Umri 18 hadi 100 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07465653

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06424288

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Inaajiri
Umri wote · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT06593327

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 30 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT06517186

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 30 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT05873634

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07761117

BiVACOR® Total Artificial Heart Early Feasibility Study

Inaajiri
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06174103

: Vascular Function in Health and Disease

InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT02966665

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06736574

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07232030

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07222813

A Study of LY3971297 in Participants With Heart Failure

InaajiriHatua 1
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07547540

Tezspire Cardiac Events PASS

InaajiriUtafiti wa uchunguzi
Umri 12 hadi 130 · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT06951867

Cholate Clearance in Fontan and Heart Failure

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT07009132

Alleviant ALLAY-HFrEF Study

Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07037459

Technical Development of Cardiovascular Magnetic Resonance Imaging

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 hadi 100 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT04927429

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.